Vaxxinity, Inc. (VAXX)

USD 0.0

(100.0%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue - - 66 Thousand 557 Thousand -
Cost of Revenue 2.23 Million 1.68 Million 1.93 Million 52 Thousand 107 Thousand
Gross Profit -2.23 Million -1.68 Million -1.87 Million 505 Thousand -107 Thousand
Operating Expenses 56.05 Million 75.97 Million 123.2 Million 32.78 Million 13.66 Million
Selling, General and Administrative Expenses 22.38 Million 28.35 Million 51.82 Million 12.21 Million 3 Million
Research and Development Expenses 33.66 Million 47.62 Million 71.37 Million 20.57 Million 10.65 Million
Other Expenses - - -8.36 Million -5.76 Million -27 Thousand
Cost and Expenses 58.28 Million 75.97 Million 125.14 Million 32.83 Million 13.66 Million
Operating Income -58.28 Million -75.97 Million -125.07 Million -32.28 Million -13.66 Million
Interest Expense 696 Thousand 514 Thousand 840 Thousand 1.18 Million 435 Thousand
Income Tax Expense -56.93 Thousand -12 Thousand 840 Thousand -4.58 Million 56 Thousand
Earnings before Tax -56.93 Thousand -75.22 Million -137.17 Million -39.95 Million -14.16 Million
Net Income -56.93 Thousand -75.21 Million -138.01 Million -35.37 Million -14.21 Million
Earnings Per Share Basic -0.45 -0.60 -1.10 -0.28 -0.11
Earnings Per Share Diluted -0.45 -0.60 -1.10 -0.28 -0.11
Weighted Average Shares Outstanding 126.5 Thousand 125.93 Million 125.39 Million 125.45 Million 125.45 Million
Weighted Average Shares Outstanding (Diluted) 126.5 Thousand 125.93 Million 125.39 Million 125.45 Million 125.45 Million
Gross Margin - - -28.35 0.91 -
EBIT Margin - - -1878.24 -67.01 -
Profit Margin - - -2091.14 -63.51 -
EBITDA -56.05 Thousand -74.29 Million -135.23 Million -31.56 Million -13.58 Million
Earnings Before Tax Margin - - -1895.08 -57.96 -

Income Statement Charts